# Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

> **NCT03681470** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 20 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Aczone Gel

## Key facts

- **NCT ID:** NCT03681470
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-09
- **Primary completion:** 2021-05-06
- **Final completion:** 2021-05-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03681470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03681470, "Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03681470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*